Wall Street's iPhone Duo Estimates Are All Over the Map — Evercore Says Supply, Not Demand, Is the Ceiling

Takeaway: Two days after Apple's foldable debut, sell-side estimates for iPhone Duo are diverging hard — from 6 million units to 35 million — but the bulls and skeptics agree on one thing: this cycle isn't priced on the tape yet, with AAPL still 0.4% under its EMA20.

What happened

Evercore ISI's Amit Daryanani reiterated a Buy rating and $365 price target on Apple in a note out this morning (published ~12:00 PM ET, syndicated via MacDailyNews and covered separately by Invezz at 12:52 PM ET). His line: "This phone is going to sell as many units as Apple can produce, at least in the near term, the next 3 to 6 months." Daryanani frames it as a supply-constrained launch, not a demand-constrained one, and pegs the revenue opportunity at roughly $25 billion if the Duo captures just 5% of Apple's installed base — with the crease-free inner display and the $1,999 starting price (below the $2,500+ some had feared) as the differentiators versus Samsung's foldables.

That $1,999 entry point undercuts prior rumors and is doing real work in the bull case across desks. Citi (Buy, $365 PT) called the Duo "the biggest new hardware category" since the Apple Watch and AirPods, and flagged the new Siri AI overhaul as the more important software story long-term. Goldman Sachs is constructive on the broader iPhone 18 split-launch strategy — a $100 bump on Pro models plus a new 2TB storage tier — as an ASP lever independent of foldable volume, with Goldman's own foldable shipment range spanning up to 35 million units this year in an optimistic scenario. TD Cowen sits at the conservative end, modeling roughly 6 million Duo units in 2H26.

Not everyone is on board. Oppenheimer (Perform) expects the Duo to become the top-selling foldable but caps 2026 production at 8–10 million units — implicitly a supply story more than a stock catalyst. Needham's Laura Martin (Hold) is the most skeptical voice: she argues a bigger screen doesn't fix Apple's structural issues, calls the AI integration "too little, too late," and flags delayed availability of the lower-end iPhone as a near-term drag. Units ship starting October 23.

Mag7 impact

AAPL-specific. The stock is trading essentially flat on the news (px $315.34, -0.43% vs EMA20, RSI 49.3), with call-tilted options flow (P/C vol 0.49, ATM IV 24.8%) suggesting the market is positioned for upside optionality rather than pricing a confirmed breakout. RVOL has run 1.67x normal this week around the launch, but the stock has faded each session since — this is a headline-driven pop, not yet a trend, per the desk's own read. The estimate dispersion itself (6M to 35M units) is the story: it means the Street hasn't converged on a model, which usually means more volatility around the next hard data point (Oct 23 sell-in reports, or Apple's own guidance on the January earnings call) rather than less. No read-through to the rest of the Mag7 — this is an idiosyncratic AAPL catalyst, not a sector one.

What to watch next

• October 23 launch/sell-in: first real read on whether Apple can supply-constrain its way to the bull case, or whether Oppenheimer's 8–10M cap is closer to reality.
• Whether AAPL can reclaim its EMA20 — the desk's own framing is that this stays a "headline pop, not a trend" until it does.
• Supply chain confirmation (component orders, TrendForce-style checks) as a cleaner tell than sell-side unit guesses over the next several weeks.
• Any update from Apple itself narrowing the estimate range — management has said nothing on hard unit targets to date.